| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000032207 |
| Receipt No. | R000036554 |
| Scientific Title | Comparison of the analgesic effect of intravenous acetaminophen with that of flurbiprofen axetil after lumbar disc surgery |
| Date of disclosure of the study information | 2018/04/16 |
| Last modified on | 2019/03/26 (Ver. 4) |
| Basic information | ||
| Public title | Comparison of the analgesic effect of intravenous acetaminophen with that of flurbiprofen axetil after lumbar disc surgery | |
| Acronym | Comparison of the analgesic effect of intravenous acetaminophen with that of flurbiprofen axetil after lumbar disc surgery | |
| Scientific Title | Comparison of the analgesic effect of intravenous acetaminophen with that of flurbiprofen axetil after lumbar disc surgery | |
| Scientific Title:Acronym | Comparison of the analgesic effect of intravenous acetaminophen with that of flurbiprofen axetil after lumbar disc surgery | |
| Region |
|
|
| Condition | ||
| Condition | lumbar disc surgery | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Postoperative pain control is important after lumbar disc surgery. Because postoperative pain is the result of activation of different pain mechanisms, including nociceptive, neuropathic and inflammatory pains, multimodal analgesic are generally used. Although opioid, especially fentanyl, based analgesia is a well-established therapy for postoperative pain control, opioids increase the incidence of PONV and respiratory depression. Acetaminophen and nonsteroidal anti-inflammatory drugs were reported to reduce opioid consumption and opioid related side effects after lumbar disc surgery. However, there are few reports compared postoperative analgesic effects between flurbiprofen and acetaminophen after lumbar disc surgery. This prospective, randomized, open-label and placebo controlled study aimed to determine whether whether flurbiprofen produces equivalent analgesic effects to acetaminophen after lumbar disc surgery. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The pain score was evaluated by numeric rating scale (NRS) from 0 to 10 at 0, 1, 3, 6, 12, 18, 24 hours postoperatively |
| Key secondary outcomes | Frequency of rescue rescue analgesics administration during 12hs, 24hs, postoperatively |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | All patients were anesthetized under total intravenous anesthesia with propofol and remifentanil according to clinical requirement. All patients received bolus administration of 0.15mg fentanyl 30 min before the end of surgery and 0.1mg fentanyl at skin closure. Group P received 10mL of saline intravenously at end of surgery, and 6, 12, and 18 hrs postoperatively Postoperative pain was evaluated by nursing staffs using a numerical rating scale (NRS) at 0, 1, 3, 6, 12, 18, 24h postoperatively. Frequency of use of rescue analgesics and consumption of rescue analgesics were recorded for 12 and 24h after surgery. | |
| Interventions/Control_2 | All patients were anesthetized under total intravenous anesthesia with propofol and remifentanil according to clinical requirement. All patients received bolus administration of 0.15mg fentanyl 30 min before the end of surgery and 0.1mg fentanyl at skin closure. Group A received 1000mg of acetaminophen intravenously at end of surgery, and 6, 12, and 18 hr postoperatively. Postoperative pain was evaluated by nursing staffs using a numerical rating scale (NRS) at 0, 1, 3, 6, 12, 18, 24h postoperatively. Frequency of use of rescue analgesics and consumption of rescue analgesics was recorded for 12 and 24h after surgery. | |
| Interventions/Control_3 | All patients were anesthetized under total intravenous anesthesia with propofol and remifentanil according to clinical requirement. All patients received bolus administration of 0.15mg fentanyl 30 min before the end of surgery and 0.1mg fentanyl at skin closure. Group A received 50mg of flurbiprofen intravenously at end of surgery, and 6, 12, and 18 hr postoperatively. Postoperative pain was evaluated by nursing staffs using a numerical rating scale (NRS) at 0, 1, 3, 6, 12, 18, 24h postoperatively. Frequency of use of rescue analgesics and consumption of rescue analgesics was recorded for 12 and 24h after surgery. | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients weighting 50-70kg who undergo elective lumbar spine surgery with ASA risk 1 or 2 | |||
| Key exclusion criteria | 1)renal disease
2)liver disease 3)ulcer 4)asthma |
|||
| Target sample size | 75 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Nagasaki Rosai Hospital | ||||||
| Division name | Department of anesthesia | ||||||
| Zip code | |||||||
| Address | 2-12-5, Setogoe, Sasebo, Nagasaki, Japan | ||||||
| TEL | 0956-49-2191 | ||||||
| yoterao@na-robyo.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Nagasaki Rosai Hospital | ||||||
| Division name | Department of anesthesia | ||||||
| Zip code | |||||||
| Address | 2-12-5, Setogoe, Sasebo, Nagasaki, Japan | ||||||
| TEL | 0956-49-2191 | ||||||
| Homepage URL | |||||||
| blaandjas@gmail.com | |||||||
| Sponsor | |
| Institute | Nagasaki Rosai Hospital Medical Office |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The Japan Labon Health and Welfare Organization |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000036554 |